Results 261 to 270 of about 93,200 (346)

Ayurvedic management of psoriatic arthritis with Dactylitis - A Case Report. [PDF]

J Ayurveda Integr Med
Peethambaran ST, Nalinakshan SDG.
europepmc   +1 more source

Additional file 1 of A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review of literature

Ritasman Baisya, Sukdev Manna, Sneha Dhali   +2 more
openalex   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Raftlin – a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study

Ozan Volkan Yurdakul, Mert Kara, Buğra İnce, C. Yıldız, Tugce Yıldız, Mehmet Serkan Kılıçoğlu, Teoman Aydın, Ömer Faruk Özer   +7 more
openalex   +1 more source

Ten-year longitudinal assessment of entheseal ultrasound in psoriasis: limited discriminatory capacity for psoriatic arthritis. [PDF]

Rheumatol Adv Pract
Genovese J, Matei I, Passeron T, Roux CH.   +3 more
europepmc   +1 more source

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE 2

, 2017
Т. В. Коротаева, E. G. Zotkin, O. B. Nesmeyanova, Н. Н. Везикова, О. Б. Ершова, N. V. Izmozzherova, М. С. Петрова, A. A. Kastanyan, S. P. Yakupova, A. S. Agafina, M. L. Stanislav, Е. А. Новодережкина, E L Nasonov, Philip J. Mease   +13 more
openalex   +2 more sources

Periodontal Status and Disease Activity in Psoriatic Arthritis and Psoriasis: A Cross-Sectional Study. [PDF]

Arch Rheumatol
Akyuz B, Durmus H, Baytımur H, Tomay Aksoy O, Basak G, Daltaban O, Alpsoy E, Sezer İ, Kacar C.   +8 more
europepmc   +1 more source

POS1250 ASSOCIATION BETWEEN METABOLIC COMORBIDITIES AND RETENTION RATES OF FIRST-LINE b/tsDMARD TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EUROPEAN REAL-WORLD RESULTS

Z. Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, M. Østergaard, J. Jørgensen, J. Heberg, A.G. Loft, Brigitte Michelsen, Gareth T. Jones, Pasoon Hellamand, Signe Møller-Bisgaard, K.Y. Jensen, M. Shoae Kazemi, P. Karimi Reikandeh, Jakub Závada, M. Bernardes, E. Vieira-Sousa, I. Castrejon, L. Otero-Varela, Cătălin Codreanu, Laura Kuusalo, Vappu Rantalaiho, A. Regierer, Andreas Reich, B. Moeller, R. Micheroli, T.K. Kvien, Sella Aarrestad Provan, K. Laas, Sigrid Vorobjov, Žiga Rotar, Katja Perdan Pirkmajer, Florenzo Iannone, F. Conti, B. Gudbjornsson, D. Di Giuseppe, M. G. H. Van de Sande, H. Yarkan-Tuğsal, Merete Lund Hetland, Bente Glintborg   +38 more
openalex   +1 more source

Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population

, 2001
Segundo González, Chaim Brautbar, Jesús Martı́nez-Borra, Antonio López‐Vázquez, R Segal, Miguel Ángel Blanco-Gelaz, Claes D. Enk, Cilly Safriman, Carlos López‐Larrea   +8 more
openalex   +2 more sources

Beyond Clinical Trials: Experience with Bimekizumab in 3 Challenging Cases of Psoriatic Arthritis. [PDF]

Mediterr J Rheumatol
Papadimitriou E, Katsigianni I, Papoutsaki M, Visvikis M, Dimitroulas T, Koutsianas C, Papagoras C.   +6 more
europepmc   +1 more source